Search Results - "Castelao, A Martínez"

Immunosuppression for Dual Kidney Transplantation with Marginal Organs: The Old Is Better Yet by Cruzado, J. M., Bestard, O., Riera, L., Torras, J., Gil‐Vernet, S., Serón, D., Rama, I., Moreso, F., Martínez‐Castelao, A., Grinyó, J. M.

“…Immunosuppressive protocols in dual kidney transplantation (DKT) are based on calcinerurin inhibitors (CNI). We wonder whether a CNI‐free immunosuppression can…”
Get full text

Prevalence and clinical characteristics of HIV type 1-infected patients receiving dialysis in Spain: results of a Spanish survey in 2006: GESIDA 48/05 study by Trullàs, J-C, Barril, G, Cofan, F, Moreno, A, Cases, A, Fernandez-Lucas, M, Martinez-Ara, J, Ceballos, M, Garcia-de-Diego, J, Muñiz, M-L, Molina, J, Martínez-Castelao, A, González-Garcia, J, Miró, J-M

“…End-stage renal diseases (ESRD) are becoming more frequent in HIV-infected patients. In Europe there is little information about HIV-infected patients on…”
Get more information

Detection and Treatment of Post Kidney Transplant Hyperglycemia: A Spanish Multicenter Cross-Sectional Study by Martı́nez-Castelao, A., Hernández, M.D., Pascual, J., Morales, J.M., Marcen, R., Errasti, P., Romero, R., Oliver, J., Jimeno, L., Garcia Martinez, J., Mendiluce, A., Garcia Cosme, P., Mazuecos, A., Danz-Guajardo, D., Alarcon, A., Marrero, D.

“…The prevalence of diabetes mellitus (DM) is greater among patients with solid organ transplants than in the general population, although the factors associated…”
Get full text

Arterial Elasticity Measurement in Renal Transplant Patients Under Anticalcineurin Immunosuppression by Martínez-Castelao, A., Sarrias, X., Bestard, O., Gil-Vernet, S., Serón, D., Cruzado, J.M., Moreso, F., Díez-Noguera, A., Grinyó, J.M.

“…Calcineurin inhibitors may be associated with decreased arterial elasticity and increased vascular risk. We measured pulse wave velocity (PWV) in large or…”
Get full text

Introducing an informative program on donation and transplantation into secondary education by López-Navidad, A, Vilardell, J, Aguayo, M.T, Albadalejo, C, Cabrer, C, Cuello, J, Echebarria, I, Martı́nez-Castelao, A, Tarrés, M, Vicente, R, Lloveras, J, Viedma, M.A

Get full text

Consensus document. Recommendations on assessing proteinuria during the diagnosis and follow-up of chronic kidney disease by Montañés Bermúdez, R, Gràcia García, S, Pérez Surribas, D, Martínez Castelao, A, Bover Sanjuán, J

“…The presence of persistently elevated urinary concentrations of protein or albumin is considered a sign of kidney damage. The diagnosis and staging of chronic…”
Get more information

Advances in diabetes mellitus, diabetic nephropathy, metabolic syndrome and cardio-vascular-renal risk by Martínez Castelao, A

“…1. Epidemiological aspects: There is evidence that the pandemic of DM is entering a stabilization phase, with a slight downturn in the rates of ESRD attributed…”
Get full text

Estimación del filtrado glomerular by Martínez-Castelao, A

Get full text

Assessment of arterial stiffness for clinical and epidemiological studies: methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry by Boutouyrie, Pierre, Fliser, Danilo, Goldsmith, David, Covic, Adrian, Wiecek, Andrzej, Ortiz, Alberto, Martinez-Castelao, Alberto, Lindholm, Bengt, Massy, Ziad A, Suleymanlar, Gultekin, Sicari, Rosa, Gargani, Luna, Parati, Gianfranco, Mallamaci, Francesca, Zoccali, Carmine, London, Gerard M

“…Epidemiological studies have highlighted the role of arterial stiffness as a risk factor for development of cardiovascular (CV) diseases. Moreover, aortic…”
Get full text

Clinical and social impact of the diabetes mellitus epidemic by Martínez-Castelao, A

Get full text

Darbepoetin alfa once every 2 weeks for treatment of anemia in dialysis patients: a combined analysis of eight multicenter trials by Mann, J, Kessler, M, Villa, G, Martinez-Castelao, A, Feldt-Rasmussen, B, Cruz, J, Hörl, W H, Mattin, C, Praml, C, Wilkie, M

“…Darbepoetin alfa has a longer half-life than epoetin-(EPO) alfa or beta, allowing administration at less frequent intervals for the treatment of renal anemia…”
Get more information

Anaemia correction in diabetic patients with chronic kidney disease without substitutive treatment: teachings from TREAT study by de Francisco, A L Martín, Aljama, P, Arias, M, Fernández, E, Górriz, J L, Gómez, J M López, Castelao, A Martínez, Portolés, J

Get full text

Acetate-free on-line PHF: how to improve hyperacetatemia and haemodynamic tolerance by Coll, E, Pérez-García, R, Martín de Francisco, A L, Galcerán, J, García-Osuna, R, Martín-Malo, A, Martínez-Castelao, A, Sánchez, B, Llopis, R, Alvarez de Lara, M A

“…The small quantity of acetate present in the dialysis fluid exposes patient's blood to an acetate concentration 30-40 times the physiological levels. This…”
Get full text

Treatment of hypertension after renal transplantation: Long-term efficacy of verapamil, enalapril, and doxazosin by Martínez-Castelao, Alberto, Hueso, Miquel, Sanz, Verónica, Rejas, Javier, Alsina, Jeroni, Grinyó, Josep M.

“…Treatment of hypertension after renal transplantation: Long-term efficacy of verapamil, enalapril, and doxazosin. Normal blood pressure is a good marker of…”
Get full text

Lipid-lowering long-term effects of six different statins in hypercholesterolemic renal transplant patients under cyclosporine immunosuppression by Martı́nez-Castelao, A, Grinyó, J.M, Gil-Vernet, S, Serón, D, Castiñeiras, M.J, Ramos, R, Alsina, J

Get full text

Lipoprotein oxidation profile in end stage renal disease patients. Role of vitamin C supplementation by Ramos, R, Gómez-Geriqué, N, Martínez-Castelao, A

“…The aim of the study was to analyze the lipid and lipoprotein oxidation profile in patients with end stage renal disease who started haemodialysis and also to…”
Get full text

Double-blind, crossover, comparative study of doxazosin and enalapril in the treatment of hypertension in renal transplant patients under cyclosporine immunosuppression by Martı́nez-Castelao, A, Hueso, M, Sanz, V, Rejas, J, Sarrias, J, Alsina, J, Grinyó, J.M

Get full text

Doxazosin GITS trough to peak ratio and 24-hour blood pressure monitoring in the management of hypertension in renal transplant patients by Martínez Castelao, A, Ibernón, M, Sarrias, X, Sanz, V, Moreso, F, Rama, I, Grinyó, J.M

“…We have studied 20 patients, 10 male, 10 female, mean age 52.5 ± 10.9 years, who received a cadaver kidney transplant between June 1996 and January 1999. The…”
Get full text

The use of echocardiography in observational clinical trials: the EURECA-m registry by Sicari, Rosa, Gargani, Luna, Wiecek, Andrzej, Covic, Adrian, Goldsmith, David, Suleymanlar, Gultekin, Parati, Gianfranco, Ortiz, Alberto, Massy, Ziad, Martinez-Castelao, Alberto, Lindholm, Bengt, Heine, Gunnar H, Fliser, Danilo, Mallamaci, Francesca, London, Gerard, Zoccali, Carmine

“…Echocardiography is the most widely used non-invasive imaging technique due to its availability, low cost, transportability and lack of ionizing radiations…”
Get full text

Clinical research based nephrology (bases for the constitution of an Evidence Based Nephrology Group in the Spanish Society of Nephrology) by Quereda, C, Pascual, J, García-López, F, Alcázar, R, Aljama, P, Amenábar, J J, Arias, M, Barrio, V, Fernández-Rodríguez, A, Fernández Juárez, G, Fernández-Lucas, M, Gallego, N, Hernández, D, Gómez-Alamillo, C, Maduell, F, Martínez Castelao, A, Marcén, R, Matesanz, R, Martín de Francisco, A L, Orte, L, Liaño, F, Luño, J, Ortuño, J, Pérez García, R, Praga, M, Saracho, R, Selgas, R, Rivera, M, Rodríguez Pérez, J C, Teruel, J L, Tato, A, Torres, A, Valdés, F

Get full text